Sări la conținut
Înapoi la căutare

Macedonia de Nord – Produse farmaceutice – Growth Hormone and Inhalation Therapy

Public Health Institution Clinic for children diseasesMacedonia de NordPublicat pe 11 nov. 2026
26 zile rămase

Descriere

Growth Hormone and Inhalation Therapy

**I.1) Description**

The European Commission, represented by the Directorate-General for Health and Food Safety, is seeking to conclude a framework agreement for the supply of growth hormone and inhalation therapy products.

**II.1.1) Information about the contracting entity**

Official name: European Commission, Directorate-General for Health and Food Safety

Address: Rue de la Loi 200, 1049 Brussels, Belgium

Country: Belgium

Contact person: European Commission, Directorate-General for Health and Food Safety

**II.1.3) Communication**

The procurement documents are available for unrestricted and full direct access, free of charge, at: TED eDelivery

Tenders or requests to participate must be submitted electronically via the eDelivery portal

**II.2.1) Description of the procurement**

The European Commission, represented by the Directorate-General for Health and Food Safety, is seeking to conclude a framework agreement for the supply of growth hormone and inhalation therapy products.

The framework agreement will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.

The estimated value of the framework agreement is EUR 12 000 000.

**III.1.1) Conditions for participation**

In order to be eligible, economic operators must provide proof that they are established in the European Economic Area (EEA) or, if established in a third country, that they have a representative in the EEA.

Economic operators must also provide proof that they have not been declared in breach of their obligations relating to the payment of social security contributions or taxes in the European Union.

**III.1.3) Information and formalities necessary for evaluating if the requirements are met**

Economic operators must submit the following documents:

- A completed and signed declaration on honour

- A copy of the economic operator's registration document

- A copy of the economic operator's articles of association

- A copy of the economic operator's VAT certificate

- A copy of the economic operator's bank guarantee

- A copy of the economic operator's insurance certificate

**III.2.1) Conditions related to the contract**

The framework agreement will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.

The estimated value of the framework agreement is EUR 12 000 000.

The framework agreement will be concluded in accordance with the principles of transparency, equal treatment and non-discrimination.

**IV.2.1) Description of the procurement**

The European Commission, represented by the Directorate-General for Health and Food Safety, is seeking to conclude a framework agreement for the supply of growth hormone and inhalation therapy products.

The framework agreement will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.

The estimated value of the framework agreement is EUR 12 000 000.

**V.2.1) Information about the award criteria**

The award criteria will be based on the most economically advantageous tender, as defined in the procurement documents.

The award criteria will take into account the following factors:

- Price

- Quality

- Delivery time

- After-sales service

**VI.3) Additional information**

The procurement documents are available for unrestricted and full direct access, free of charge, at: TED eDelivery

Tenders or requests to participate must be submitted electronically via the eDelivery portal

The deadline for the submission of tenders or requests to participate is 15/09/2023 at 12:00 CET.

The deadline for the submission of questions is 01/09/2023 at 12:00 CET.

The European Commission, represented by the Directorate-General for Health and Food Safety, reserves the right to reject any tender or request to participate that does not comply with the procurement documents.

The European Commission, represented by the Directorate-General for Health and Food Safety, reserves the right to cancel the procurement procedure at any time.

**VII.2) Information about the award of the contract**

The award of the contract will be based on the most economically advantageous tender, as defined in the procurement documents.

The award of the contract will take place within 30 days of the deadline for the submission of tenders or requests to participate.

The award of the contract will be published on the TED eDelivery portal.

The contract will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.

The estimated value of the contract is EUR 12 000 000.

**VIII.2) Information about the award of the contract**

The award of the contract will be based on the most economically advantageous tender, as defined in the procurement documents.

The award of the contract will take place within 30 days of the deadline for the submission of tenders or requests to participate.

The award of the contract will be published on the TED eDelivery portal.

The contract will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.

The estimated value of the contract is EUR 12 000 000.

Coduri CPV

Pharmaceutical products

Documente și transmitere

Rezumat AI
Conectează-te pentru un rezumat AI

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Achiziții similare